Heterologous Expression and Antimicrobial Targets of a Novel Glycine-Rich Antimicrobial Peptide from Artemia franciscana.

IF 5.4 2区 医学 Q1 CHEMISTRY, MEDICINAL
Marine Drugs Pub Date : 2025-08-17 DOI:10.3390/md23080330
Ming Tao, Aobo Sun, Huishi Shao, Huaiyuan Ye, Guangming Yu, Daigeng Chen, Wei Zhang
{"title":"Heterologous Expression and Antimicrobial Targets of a Novel Glycine-Rich Antimicrobial Peptide from <i>Artemia franciscana</i>.","authors":"Ming Tao, Aobo Sun, Huishi Shao, Huaiyuan Ye, Guangming Yu, Daigeng Chen, Wei Zhang","doi":"10.3390/md23080330","DOIUrl":null,"url":null,"abstract":"<p><p>The growing problem of antimicrobial resistance in aquaculture, caused by the excessive and unregulated use of antibiotics, highlights the critical necessity for developing new anti-infective solutions. Based on the characteristics of glycine-rich antimicrobial peptides (AMPs) and transcriptomic data, an antimicrobial peptide, namely <i>Af</i>Rgly1, was discovered in this study. Subsequently, the peptide was obtained through heterologous expression in <i>E. coli</i>, and its antibacterial spectrum was determined. Molecular dynamics simulation and molecular biology experiments were conducted to explore the antibacterial target of <i>Af</i>Rgly1. Results showed that the mRNA expression level of <i>Af</i>Rgly1 was significantly upregulated after <i>Vibrio alginolyticus</i> infection. <i>Af</i>Rgly1 has broad-spectrum antibacterial activity targeting on bacterial cell membrane, and it may also interact with bacterial DNA. <i>Af</i>Rgly1 displayed low selectivity for fish red blood cells. These results indicate that <i>Af</i>Rgly1 is an antimicrobial peptide with considerable potential for application in the development of therapeutic agents.</p>","PeriodicalId":18222,"journal":{"name":"Marine Drugs","volume":"23 8","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12387859/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Marine Drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/md23080330","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

The growing problem of antimicrobial resistance in aquaculture, caused by the excessive and unregulated use of antibiotics, highlights the critical necessity for developing new anti-infective solutions. Based on the characteristics of glycine-rich antimicrobial peptides (AMPs) and transcriptomic data, an antimicrobial peptide, namely AfRgly1, was discovered in this study. Subsequently, the peptide was obtained through heterologous expression in E. coli, and its antibacterial spectrum was determined. Molecular dynamics simulation and molecular biology experiments were conducted to explore the antibacterial target of AfRgly1. Results showed that the mRNA expression level of AfRgly1 was significantly upregulated after Vibrio alginolyticus infection. AfRgly1 has broad-spectrum antibacterial activity targeting on bacterial cell membrane, and it may also interact with bacterial DNA. AfRgly1 displayed low selectivity for fish red blood cells. These results indicate that AfRgly1 is an antimicrobial peptide with considerable potential for application in the development of therapeutic agents.

一种新型富甘氨酸抗菌肽的异源表达及抑菌靶点研究。
由于过度和不受管制地使用抗生素,水产养殖中抗菌素耐药性问题日益严重,这突出表明迫切需要开发新的抗感染解决方案。根据富含甘氨酸的抗菌肽(AMPs)的特性和转录组学数据,本研究发现了一种抗菌肽,即AfRgly1。随后,通过大肠杆菌外源表达获得该肽,并测定其抗菌谱。通过分子动力学模拟和分子生物学实验探索AfRgly1的抑菌靶点。结果显示,AfRgly1 mRNA表达水平在溶藻弧菌感染后显著上调。AfRgly1具有针对细菌细胞膜的广谱抗菌活性,并可能与细菌DNA相互作用。AfRgly1对鱼红细胞的选择性较低。这些结果表明,AfRgly1是一种抗菌肽,在治疗剂开发中具有很大的应用潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Marine Drugs
Marine Drugs 医学-医药化学
CiteScore
9.60
自引率
14.80%
发文量
671
审稿时长
1 months
期刊介绍: Marine Drugs (ISSN 1660-3397) publishes reviews, regular research papers and short notes on the research, development and production of drugs from the sea. Our aim is to encourage scientists to publish their experimental and theoretical research in as much detail as possible, particularly synthetic procedures and characterization information for bioactive compounds. There is no restriction on the length of the experimental section.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信